Skip to search.
 TSX Up 0.27% TSX Ventures Up 0.18%

Novartis AG (NVS)

-NYSE
99.86 Up 1.25(1.27%) 4:02PM EDT
|After Hours : 99.80 Down 0.06 (0.06%) 5:56PM EDT
Add to Portfolio
Prev Close:98.61
Open:100.01
Bid:99.80 x 100
Ask:102.00 x 100
1y Target Est:104.57
Beta:0.65
Next Earnings Date:N/A
Day's Range:98.92 - 100.12
52wk Range:82.27 - 103.50
Volume:1,405,448
Avg Vol (3m):2,082,920
Market Cap:239.53B
P/E (ttm):24.19
EPS (ttm):4.13
Div & Yield:2.82 (2.80%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVSUp 1.27%239.53B
MRKDown 1.08%161.38B
PFEDown 1.32%210.40B
SNYUp 0.99%130.56B

Key Statistics

Forward P/E (1 yr):17.99
P/S (ttm):4.41
Ex-Dividend Date:02-Mar-15

Analysts

Annual EPS Est (Dec-15) :5.21
Quarterly EPS Est (Mar-15) :1.07
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):2.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback